Clinical Trials Directory

Trials / Completed

CompletedNCT01885390

Registry to Evaluate the ROX COUPLER in Patients With Resistant or Uncontrolled Hypertension

ROX CONTROL HTN Registry: To Evaluate the ROX Coupler in Patients With Resistant or Uncontrolled Hypertension

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
83 (actual)
Sponsor
ROX Medical, Inc. · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this registry is to evaluate the safety and performance of the ROX COUPLER in patients with treatment-resistant or uncontrolled hypertension.

Conditions

Interventions

TypeNameDescription
DEVICEROX COUPLERThe COUPLER will be used to create an anastomosis in the iliac region (between the iliac artery and vein).

Timeline

Start date
2014-03-01
Primary completion
2019-05-05
Completion
2019-05-05
First posted
2013-06-25
Last updated
2019-05-13

Locations

4 sites across 3 countries: Belgium, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT01885390. Inclusion in this directory is not an endorsement.